Amneal Pharmaceuticals Inc (AMRX)
8.19
-0.16
(-1.92%)
USD |
NASDAQ |
Sep 27, 16:00
8.19
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Cash from Investing (Quarterly): -6.465M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -6.465M |
| March 31, 2024 | -19.76M |
| December 31, 2023 | -31.69M |
| September 30, 2023 | -13.48M |
| June 30, 2023 | -12.28M |
| March 31, 2023 | -11.74M |
| December 31, 2022 | -11.47M |
| September 30, 2022 | -49.33M |
| June 30, 2022 | -16.12M |
| March 31, 2022 | -97.40M |
| December 31, 2021 | -86.97M |
| September 30, 2021 | -11.63M |
| June 30, 2021 | -82.89M |
| Date | Value |
|---|---|
| March 31, 2021 | -12.69M |
| December 31, 2020 | -31.80M |
| September 30, 2020 | -14.78M |
| June 30, 2020 | -8.927M |
| March 31, 2020 | -262.04M |
| December 31, 2019 | -4.767M |
| September 30, 2019 | 29.98M |
| June 30, 2019 | -23.33M |
| March 31, 2019 | -21.47M |
| December 31, 2018 | 5.321M |
| September 30, 2018 | -40.78M |
| June 30, 2018 | -341.42M |
| March 31, 2018 | -19.50M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-262.04M
Minimum
Mar 2020
29.98M
Maximum
Sep 2019
-37.81M
Average
-14.13M
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -2.199B |
| Amphastar Pharmaceuticals Inc | -69.90M |
| Nutriband Inc | -0.0389M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 39.66M |
| Cash from Financing (Quarterly) | -35.09M |
| Free Cash Flow | 176.08M |
| Free Cash Flow Per Share (Quarterly) | 0.0884 |
| Free Cash Flow to Equity (Quarterly) | 47.37M |
| Free Cash Flow to Firm (Quarterly) | 82.27M |
| Free Cash Flow Yield | 8.35% |